BB
PCYC

BB Biotech’s PHARMACYCLICS INC PCYC Stock Holding History

BB Biotech’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-731,542
Closed -$89.4M – 28
2014
Q4 		$89.4M Hold
731,542
– – 2.9% 12
2014
Q3 		$85.9M Hold
731,542
– – 3.49% 10
2014
Q2 		$65.6M Buy
731,542
+95,000
+15% +$8.91M 3.12% 10
2014
Q1 		$63.8M Hold
636,542
– – 3.29% 11
2013
Q4 		$67.3M Buy
636,542
+237,512
+60% +$28.8M 3.6% 9
2013
Q3 		$55.2M Buy
+399,030
New +$44.3M 3% 11

Other funds holding PCYC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BB Biotech's PCYC Position: Q1 2015 in Review

BB Biotech sold out of PHARMACYCLICS INC (PCYC) in Q1 2015, closing a stake of 731,542 shares — an estimated $89.4M sold.

BB Biotech first reported a position in PCYC in Q3 2013 and held it in 6 quarters. The position peaked at $89.4M in Q4 2014. 336 funds tracked by Wall St. Rank hold PCYC as of Q1 2015.

  • BB Biotech reported no remaining PHARMACYCLICS INC position as of Q1 2015 after selling out during the quarter.
  • BB Biotech sold 731,542 PHARMACYCLICS INC shares in Q1 2015, an estimated $89.4M.
  • BB Biotech first reported a position in PHARMACYCLICS INC in Q3 2013 and held it in 6 quarters.
  • BB Biotech's PHARMACYCLICS INC position peaked at $89.4M in Q4 2014.
  • 336 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q1 2015.

Based on BB Biotech's 13F filing for Q1 2015, filed 14 May 2015.